PROCEPT BioRobotics Corporation - Common Stock — Cash Flow (NASDAQ:PRCT) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -57.33 M-80.38 M-108 M-99.21 M-48.98 M -70.13 M Cash from investing activities -592 K-2.65 M-25.21 M-4.41 M-9.36 M -10.43 M Cash from financing activities 262.12 M3.61 M167.79 M180.13 M11.19 M 10.12 M Free cash flow -57.33 M-80.38 M-108 M-99.21 M-58.34 M -80.57 M

News

PROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

PROCEPT BioRobotics Corporation (PRCT) Q1 2026 Earnings Call Transcript

PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates

PROCEPT BioRobotics: An Undervalued Surgical Robotics Growth Story (NASDAQ:PRCT)

PROCEPT BioRobotics launches HYDROS system in UK

Tuesday’s insider activity: Major buys at PROCEPT and Mesa Labs

Procept Biorobotics director Desai buys PRCT shares worth $10.4m

Alaleh Nouri, EVP at Procept Biorobotics, sells $163k in shares

PROCEPT BioRobotics Corporation (PRCT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Baird initiates Procept BioRobotics stock rating at Neutral

Procept BioRobotics appoints Daniel Puckett to board and audit committee

Procept BioRobotics at TD Cowen Conference: Strategic Growth Focus